| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/03/2009 | US20090221578 Organic Compounds |
| 09/03/2009 | US20090221566 Inhibitors of phosphodiesterase type-iv |
| 09/03/2009 | US20090221548 Melanin concentrating hormone receptor-1 antagonists |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221475 Treatment of lung disorders |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090220626 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 09/03/2009 | US20090220580 Percutaneous Absorption Formulation |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220496 Novel uses for anti-ige therapy |
| 09/03/2009 | US20090220467 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis |
| 09/03/2009 | US20090220464 Mesenchymal stem cells and uses therefor |
| 09/03/2009 | CA2716554A1 Fibrosis inhibitor |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2716397A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 09/03/2009 | CA2714721A1 Anti-allergic agent |
| 09/03/2009 | CA2713776A1 New macrolides and their use |
| 09/03/2009 | CA2711733A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096105A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
| 09/02/2009 | EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 09/02/2009 | EP2094646A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094271A2 Drug combinations for treating airway diseases |
| 09/02/2009 | EP2094255A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 09/02/2009 | EP1951282A4 Treatment of hypersensitivity |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1228125A4 Process for making aqueous coated beadlets |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518629A Traditional Chinese medicine composition for treating asthma and preparation method thereof |
| 09/02/2009 | CN101518617A Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
| 09/02/2009 | CN101518613A Chinese herbal decoction for treating cough |
| 09/02/2009 | CN101518592A Granule used for treating cold due to wind-heat and preparation method thereof |
| 09/02/2009 | CN101518587A Traditional Chinese medicine for treating laryngeal carcinoma |
| 09/02/2009 | CN101518585A Holding prescription for treating influenza |
| 09/02/2009 | CN101518580A Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 09/02/2009 | CN101518567A Immediate throat cool buccal dripping pill and detection method thereof |
| 09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518542A Liquiritin preparation and application thereof |
| 09/02/2009 | CN101518541A Application of liquiritin apioside |
| 09/02/2009 | CN101518537A Preventives/remedies for inflammatory airway diseases |
| 09/02/2009 | CN101518532A Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 09/02/2009 | CN101518526A Drug combination |
| 09/02/2009 | CN101518523A Glycyrrhizin preparation and application thereof for eliminating phlegm and relieving cough |
| 09/02/2009 | CN101518519A Naringin slow-release tablet and method for preparing same |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2460140C Compositions for treatment of common cold |
| 09/01/2009 | CA2438799C Preventative of therapeutic agent for inflammatory respiratory tract disease |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103479A2 Cristallines, enantiomerically pure salt form of a betamimetic agent, and the use thereof as a medicament |
| 08/27/2009 | WO2009083738A3 Rna delivery vehicles |
| 08/27/2009 | WO2009079405A3 Assessing treatment compliance |
| 08/27/2009 | WO2009063215A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009063202A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
| 08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/27/2009 | WO2009033668A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2008142513A3 Phosphate-modified oligonucleotide analogs with immunostimulatory activity |
| 08/27/2009 | WO2008135819A8 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
| 08/27/2009 | US20090215846 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
| 08/27/2009 | US20090215811 Novel Pharmaceutical Composition and Its Use in a Method For Treatment of Patients With Upper Respiratory Mucosal Congestion |
| 08/27/2009 | US20090215807 Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated Diseases |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215734 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| 08/27/2009 | US20090215732 Combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| 08/27/2009 | US20090215717 Sulfated oligosaccharides |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone |
| 08/27/2009 | US20090214520 Soluble CLCA-1 and antagonists to CLCA-1 |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214444 Poly aromatic sodium channel blockers |
| 08/27/2009 | CA2715771A1 Adrenomedullin production enhancer |
| 08/27/2009 | CA2712706A1 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093219A1 Crystalline enantiomer free salt form of a betamimetic and its use as medicine |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2092941A2 Drug releasing coatings for medical devices |
| 08/26/2009 | EP2092935A1 Pharmaceutical compositions for the treatment of asthma |
| 08/26/2009 | EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 08/26/2009 | EP2091549A1 Compositions and methods for treating infectious bronchitis |
| 08/26/2009 | EP1631569B1 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |